Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entyvio in moderate to severe Crohn's disease
NCT00783692Phase 3Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Mar 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of vedolizumab in Crohn's disease, sponsored by Millennium Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
vedolizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00783692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783692.